February 4th is World Cancer Day
World Cancer Day is an annual global event taking place every year on 4 February that unites the world’s population in the fight against cancer. Its goal is to save millions of preventable deaths each year.
On this day and throughout the month of February, the month of love, hundreds of cities and organizations around the world link together as one under the sole purpose of raising awareness and education about the disease and pressing governments to take action.
The theme for Cancer Day this year until 2018 is “We Can, I Can,” highlighting how everyone – as a collective or as individuals – can do their part to reduce the global burden of cancer.
Currently, 8.2 million people die from cancer worldwide every year, out of which, 4 million people die prematurely (aged 30 to 69 years).
World Cancer Day is the ideal opportunity to spread the word and raise the profile of cancer in people’s minds.
We encourage you to visit the World Cancer Day website and check out the local events in your area.
As March awareness month comes to a close, we would like to reflect upon our reach and the impact these campaigns have on the lives of Canadians throughout the country. More than ever this year, the international and national community has come together to bring more awareness to colorectal cancer everywhere. We thank all of our supporters/followers for helping to spread the word and hope that you will continue to do – There is still work to be done. Continue to follow us and the social media platforms of our partners: N2Y & Foods That Fight. And continue to share, not only our content but also that of your own. Please send us private messages on any news stories that you have or survivor stories of your own. You are not alone, WE are in this fight together and will one day be able proudly say that WE BEAT THIS DISEASE TOGETHER!
Niagara Health System’s (NHS) Colorectal Screening Program, in partnership with Juravinski Cancer Centre in Hamilton, brought the Giant Colon Tour to the Pen Centre in St. Catharines Ontario as part of Colorectal Cancer Awareness Month.
Colorectal Cancer Association of Canada’s (CCAC) pink inflatable walk-through reproduction of the human colon is 40 feet long and eight feet high. The exhibit attracted over 2,300 visitors on Friday March 4th and Saturday March 5th, 2016.
The NHS partnered with The Giant Colon Tour, an educational exhibit part of the CCAC campaign that seeks to educate Canadians that this disease is preventable, treatable and beatable.
A team of registered nurses and health promotion specialists from Niagara Health System’s Endoscopy department were on hand to offer information about screening and prevention. Dr. Meghan Davis, CCO Regional Primary Care Lead and Dr. Pierre Major, the Chair of the CCAC’s Medical Advisory Board were also on hand to speak to the numerous visitors from the Niagara Region.
The message on prevention and screening reached thousands more in the region due to the extensive media coverage that was orchestrated by NHS Communications Specialist Steven Gallagher. Below are the links to some of the coverage:
A special thanks to Ruth Peters (NHS) and Andi Sinclair (Brock University), who were instrumental in bringing The Giant Colon Tour to the region for the second time since 2010.
I am proud to say that on Sunday, December 28th, I made my first donation on behalf of VØID Cancer (www.voidcancer.com) to The Colorectal Cancer Association of Canada for $948.65 using proceeds collected from the purchase of my Rockstar Mind guitar training products.
The donation will be used to continue to educate and support patients and caregivers much like the CCAC has done for my father and my family.
Without them, I’m not sure where my father would be right now.
So thank you again to everyone who contributed and asked me to help them achieve their dream of playing guitar.
We did it….together!
And in 2015, I plan to raise the stakes, expand the company, and donate even more money to this great cause!
In short, even though I end the year by giving, I am really the one who is left with a feeling of gratitude.
And I think it’s fitting to take a page from my band The Envy and say “I Never Wanna Lose This Feeling”.
With that said, I would like to share an unreleased music video for a track with the same name.
Happy New Year and all the best to you and your family in 2015!
Steve (aka VØID)
For Steve Mastroianni (aka VØID), 2013 was a year he won’t soon forget.
After touring all over the world with top Rock Bands such as KISS, Our Lady Peace, and Finger Eleven, Steve’s life took a devastating turn for the worse when his father, Anthony Mastroianni, told him that he’s just been diagnosed with Stage 4 Colon Cancer.
“When my father was diagnosed last Spring, I knew right away that I would put my music career on hold and stop at nothing to get him back to 100% and onto the golf course. I didn’t know exactly how we would do it, but I knew that his passion would be a KEY component to his recovery.” said Steve.
Shortly after the diagnosis, the Mastroianni family was approached by Fil from the Colorectal Cancer Association of Canada (CCAC), offering to coach everyone involved through the difficult time.
“Fil answered EVERY single one of our questions about the upcoming process, educated us about how Colorectal Cancer functions in the body, and connected us with all the people who helped my father fully recover and return to the golf course.” said Steve.
Despite the emotional rollercoaster ride that was 2013-2014, after two surgeries, countless visits to the hospital, and the horrors of spending more time in the emergency room than his previous 28 years combined, Steve is proud to say that they achieved their goal on July 22nd, 2014, just over one year after the diagnosis.Photo: “The path that Fil and the CCAC set out for us in 2013 was the crucial element that ensured my Dad spent this summer out of the hospital and on the golf course. I may have toured with KISS, but Fil is the real Rockstar here!” said Steve.
So WHY VØID Cancer?
After traveling the world for 10 years with a guitar on his back, Steve is no stranger to communicating his message to large crowds.
However, it was his experience with his father this past year that would help to put everything in perspective and inspire him to use his guitar to make an even bigger impact in the world.
His goal is to Teach and Inspire new Guitar Players around the world, while donating proceeds to the CCAC to further Cancer Research and introduce new programs for those who are suffering from this horrible disease.
He calls this movement VØID Cancer and his mission is to Eliminate Cancer: One Note at a Time.
He plans to accomplish this by selling his online coaching platform & digital products as well as through LIVE workshops for patients, caregivers, and anyone else who would like to learn how to create beautiful music and lasting change.
If you or someone you love has always dreamed of playing guitar, or just wants to give it a try, then there is no better time to learn than now.
“I can’t think of any better incentive to practice than knowing that proceeds will be going to further Cancer research.” said Steve.
Even his Rockstar mentor Gene Simmons approves of his new venture: “VØID is a special guy and what he is doing with VØID Cancer is admirable.” – Gene Simmons
Please click the link below and sign up to find out how you can get started today.
New molecular features of colorectal cancer and five colon cancer subtypes are identified with proteomics
Researchers report first large-scale integrated proteomic and genomic analysis of a human cancer: Identification of new molecular features of colorectal cancer
Investigators who analyzed 95 human colorectal tumor samples have determined how gene alterations identified in previous analyses of the same samples are expressed at the protein level. The integration of proteomic and genomic data, or proteogenomics, provides a more comprehensive view of the biological features that drive cancer than genomic analysis alone and may help identify the most important targets for cancer detection and intervention. The results of this study appeared online July 20, 2014, in Nature.
The colorectal study produced several key findings:
- Measurements of messenger RNA abundance did not reliably predict protein abundance. The investigators were not surprised by this discordance, because many regulatory controls lie between RNA and protein expression. However, it did demonstrate that RNA analyses do not necessarily give a correct indication of protein levels.
- Most of the focal amplifications (increased amounts of certain chromosome segments) observed in the earlier genomic analyses of the same tumors did not result in corresponding elevations in protein level. Proteomic analyses identified a few amplifications that had dramatic effects on protein levels and may represent potentially important targets for diagnosis or therapeutic intervention.
- Proteomics identified five colon cancer subtypes, including classifications that could not be derived from genomic data. Protein expression signatures for one of the subtypes indicated molecular characteristics associated with highly aggressive tumors with poor clinical outcome.
These findings, by Clinical Proteomic Tumor Analysis Consortium (CPTAC) investigators, including Henry Rodriguez, Ph.D., director of the Office of Cancer Clinical Proteomics Research, NCI, and Daniel C. Liebler, Ph.D., Vanderbilt University School of Medicine, Nashville, were made possible because of genomic analyses that were done on the same tumors in 2012 by The Cancer Genome Atlas (TCGA) Research Network. The CPTAC study provided a clear demonstration of how proteomics can be used to help understand how genomic abnormalities drive cancer.
Ottawa Hospital hopes diagnosis lab will aid cancer treatment: This is the future for target therapy
The Ottawa Hospital is hoping a new diagnostic centre for identifying cancers that could be treated through less invasive means will be open by the fall.
The hospital says it has raised half the $3 million it needs to open its own Molecular Oncology Diagnostics Laboratory.
Currently cancer patients in Ottawa who want to know if their particular disease could be treated with a targeted therapy instead of a one-size-fits all treatment like chemotherapy have to wait months before their samples can be assessed at labs in Toronto.
The Ottawa Hospital, which treated 24,000 cancer patients last year, said having a lab here in the city could cut the wait time for results to days instead of months.
The head of the new lab, Dr. Bryan Lo, said targeted treatments, if available, are far preferable to other options.
“When a cancer is discovered we’ll really be characterizing genetically this cancer to try to determine if we can apply some of these newer targeted therapies. Therapies that are much less toxic and with fewer side effects,” said Lo.
Jenn Miriguay, 37, has been living with cancer for five years and has gone through an arsenal of treatments, including chemotherapy, and lived through the side effects.
“It’s an all-hazards approach, you throw everything at it that you can and hope and pray that it works,” she said.
She said the new diagnosis centre has raised her hopes there will be an alternative way to treat her disease.
“The kids aren’t going to have a grumpy mommy all the time, my husband’s going to have a wife who wants to actively participate in life,” she said.
The clinic, when it opens, will focus on analyzing samples from patients with breast, lung, melanoma and colorectal cancers, the four most common types of cancers for which targeted therapies are available.
The hospital hopes within a year of opening it will then be able to accept samples from all cancer patients.
On May 15, 2013 The Colorectal Cancer Association of Canada participated in the symposium titled “CANCER AND CULTURE: A DIFFERENT APPROACH” sponsored by la Coalition Priorité Cancer au Québec and l’Alliance des communautés culturelles pour l’égalité dans la santé et les services sociaux (ACCÉSSS). The symposium discussed the various differences of ethnocultural clients, patient-caregiver relationships in the intercultural context, focusing in particular on ways to improve the understanding and participation of patients and their families in public health programs for prevention and screening, and cancer treatment.
For more photos, please visit our Facebook page.
Lisa Blobstein was just 36 years old and a new mom when her husband was diagnosed with advanced colon cancer. Her 38 year old husband Steve lost his heroic battle in June 2011. Their son AJ was just 17 months old at the time. Hear Lisa’s story as we launch Colorectal Cancer Awareness Month with National Dress in Blue day and learn about the 2nd annual softball game she is planning in her husband’s memory.
Lisa and our very own Frank Pitman at last year’s event
Second Annual Softball Game in memory of Steve Lisiak
Saturday June 1st, 2013 at Alexander Park in Pierrefonds, Quebec
For more information, please contact Lisa Blobstein at 514-624-6954 or email@example.com
It was with great enthusiasm that the CCAC welcomed the Olympic gold-medal winning short track speed skater at its offices in Montreal to accept a donation of $1000.00. François-Louis Tremblay generously chose our cause in honour of his courageous mother who survived colorectal cancer.
Francois-Louis Tremblay is an accomplished athlete who participated in the Winter Olympics in 2002, 2006 and 2010. Tremblay has won five Olympic medals, including two gold. However, what catches our attention is not the number of medals won, but his active lifestyle that makes him a role model for young and old alike. Having supported his mother in her fight against colorectal cancer, Francois-Louis Tremblay is well aware of the risks posed by the disease and ways to prevent it. Our meeting with the athlete was also an opportunity to discuss the importance of a healthy lifestyle and early detection, which can in turn prevent him from developing the disease.
Colorectal cancer is preventable through early detection!
Many thanks and good luck to the athlete in future competitions.